Entero Healthcare Solutions will hold a board meeting on February 12, 2026, to consider and approve the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025 (Q3). The trading window for company securities remains closed for designated persons and their immediate relatives until 48 hours after the results are declared.
Board Meeting Announcement
A meeting of the Board of Directors of Entero Healthcare Solutions is scheduled for February 12, 2026. The primary agenda is to review and approve the unaudited financial results.
Financial Results on the Agenda
The board will consider and approve the unaudited standalone and consolidated financial results for the third quarter (Q3) and nine months period, which ended on December 31, 2025.
Trading Window Closure
The trading window, which restricts company employees and related parties from trading in Entero Healthcare Solutions’ securities, remains closed. It will reopen 48 hours after the declaration of the aforementioned financial results.
Source: BSE
